The investigational glucagon-like peptide-1, once-weekly dulaglutide, appears to control diabetes in relatively recently diagnosed patients better than daily metformin monotherapy, researchers reported here.
Read more
medPage – Dulaglutide Tops Metformin for Type 2 Diabetes
Posted in Drugs